Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus
- PMID: 6190947
Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus
Abstract
To assess the effects of chronic virus infection on NK cells, the related phenomena of interferon (IFN) production, NK cell activation, and resistance to tumor implants were studied in mice persistently infected with lymphocytic choriomeningitis virus (LCMV). NK cells from these LCMV-carrier mice displayed augmented killing of the NK-sensitive YAC-1 target cell. They did not lyse the more resistant targets L-929 and P815, whereas NK cells from acutely infected mice efficiently lysed all three cell types. The plasma from LCMV-carrier mice contained an antiviral substance identified as IFN type I, based on species specificity, virus nonspecificity, resistance to pH 2, and sensitivity to antibody to type I IFN. IFN titers in plasma from LCMV-carrier mice were 32 to 64 U/ml, about 20-fold less than those in acutely infected mice. Both the IFN and NK cell levels continuously remained elevated in the LCMV carrier mice up to at least 6 months of age. IFN is known to activate NK cells and to induce their blastogenesis in vivo. As determined by centrifugal elutriation, large NK blast-size cells were isolated from the spleens of acutely infected mice, but not from either normal or LCMV-carrier mice, suggesting augmented NK cell-mediated lysis in the absence of enhanced proliferation. Poly inosinic-cytidylic acid induced high levels of NK cell-mediated cytotoxicity and blastogenesis in both control and LCMV-carrier mice, but IFN was induced to lower levels in carriers as compared with controls. Coincidental with augmented NK cell activity, the LCMV-carrier mice rejected intravenously injected 125IUdR-labeled tumor cells more efficiently than did normal mice. Thus, LCMV carrier mice have low levels of type I IFN, moderately augmented NK cell activity lasting for at least 6 months, and increased resistance to tumor cell implants. This indicates that augmented NK cell-mediated cytotoxicity can be maintained in vivo over prolonged periods of time in the presence of chronic low-level IFN stimulation.
Similar articles
-
Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.J Immunol. 1985 Nov;135(5):3537-41. J Immunol. 1985. PMID: 2413125
-
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.J Immunol. 1983 Sep;131(3):1531-8. J Immunol. 1983. PMID: 6309965
-
NK cell response to viral infections in beta 2-microglobulin-deficient mice.J Immunol. 1995 Jan 15;154(2):780-9. J Immunol. 1995. PMID: 7529286
-
Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review.
-
[K (killer) and NK (natural killer) cells: characteristics, functions and biological properties (author's transl)].Wien Klin Wochenschr. 1980 Feb 29;92(5):147-56. Wien Klin Wochenschr. 1980. PMID: 6156545 Review. German.
Cited by
-
Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. I. Analysis of natural immune defense.Cancer Immunol Immunother. 1985;19(3):183-8. doi: 10.1007/BF00199224. Cancer Immunol Immunother. 1985. PMID: 3847288 Free PMC article.
-
Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.J Exp Med. 2000 Jan 3;191(1):129-38. doi: 10.1084/jem.191.1.129. J Exp Med. 2000. PMID: 10620611 Free PMC article.
-
Latent herpesvirus infection arms NK cells.Blood. 2010 Jun 3;115(22):4377-83. doi: 10.1182/blood-2009-09-245464. Epub 2010 Feb 4. Blood. 2010. PMID: 20139098 Free PMC article.
-
Heterologous immunity between viruses.Immunol Rev. 2010 May;235(1):244-66. doi: 10.1111/j.0105-2896.2010.00897.x. Immunol Rev. 2010. PMID: 20536568 Free PMC article. Review.
-
Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells.J Exp Med. 2015 Jul 27;212(8):1153-69. doi: 10.1084/jem.20142047. Epub 2015 Jun 29. J Exp Med. 2015. PMID: 26122661 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials